Chia, S. K., Fasching, P. A., Crown, J., Slamon, D. J., Loi, S., Im, S., Press, M. F., Martín, M., Lipatov, O., Nowecki, Z., Kukielka-Budny, B., Stroyakovskiy, D., Blancas, I., Vervier, K., Li, Z., Gonzalez, J. P. Z., Taran, T., Su, F., Prat, A., Bardia, A. (2026). Prognostic and predictive impact of baseline gene expression (exp) in the NATALEE trial of adjuvant (adj) ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in HR+/HER2− early breast cancer (EBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.501